Literature DB >> 18395031

Fibroids and reproductive outcomes: a systematic literature review from conception to delivery.

Peter C Klatsky1, Nam D Tran, Aaron B Caughey, Victor Y Fujimoto.   

Abstract

We examined the published relationship between uterine fibroids and reproductive outcomes. Submucosal fibroids had the strongest association with lower ongoing pregnancy rates, odds ratio, 0.5; 95% confidence interval, 0.3-0.8, primarily through decreased implantation. Cumulative pregnancy rates appeared slightly lower in patients with intramural fibroids 36.9% vs 41.1%, which may reflect biases in the literature; however, patients with intramural fibroids also experienced more miscarriages, 20.4% vs 12.9%. Adverse obstetric outcomes are rare and may reflect age or other differences in fibroid populations. Increased risk of malpresentation (odds ratio, 2.9; 2.6-3.2), cesarean (odds ratio, 3.7; 3.5-3.9), and preterm delivery (odds ratio, 1.5; 1.3-1.7) are reported; however, the incidence of labor dystocia was low (7.5%). There was no conclusive evidence that intramural or subserosal fibroids adversely affect fecundity. More prospective, controlled trials are needed to assess the effects of myomectomy. Good maternal and neonatal outcomes are expected in pregnancies with uterine fibroids.

Entities:  

Mesh:

Year:  2008        PMID: 18395031     DOI: 10.1016/j.ajog.2007.12.039

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  81 in total

1.  Contemporary management of fibroids in pregnancy.

Authors:  Hee Joong Lee; Errol R Norwitz; Julia Shaw
Journal:  Rev Obstet Gynecol       Date:  2010

2.  The utility of caesarean myomectomy as a safe procedure: a retrospective analysis of 21 cases with review of literature.

Authors:  Ramesh Kumar R; Manjula Patil; Shruthi Sa
Journal:  J Clin Diagn Res       Date:  2014-09-20

3.  Introduction of Female Reproductive Processes and Reproductive Diseases.

Authors:  Jiajia Zhang; Jiao Li; Jie Yan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Uterine leiomyomata and fecundability in the Right from the Start study.

Authors:  Gayle Johnson; Richard F MacLehose; Donna D Baird; Shannon K Laughlin-Tommaso; Katherine E Hartmann
Journal:  Hum Reprod       Date:  2012-07-18       Impact factor: 6.918

Review 5.  The impact of uterine leiomyomas on reproductive outcomes.

Authors:  H Cook; M Ezzati; J H Segars; K McCarthy
Journal:  Minerva Ginecol       Date:  2010-06

6.  Fetal exposure to nonsteroidal anti-inflammatory drugs and spontaneous abortions.

Authors:  Sharon Daniel; Gideon Koren; Eitan Lunenfeld; Natalya Bilenko; Ronit Ratzon; Amalia Levy
Journal:  CMAJ       Date:  2014-02-03       Impact factor: 8.262

7.  Use of depot medroxyprogesterone acetate and prevalent leiomyoma in young African American women.

Authors:  Q E Harmon; D D Baird
Journal:  Hum Reprod       Date:  2015-03-27       Impact factor: 6.918

Review 8.  The estimated annual cost of uterine leiomyomata in the United States.

Authors:  Eden R Cardozo; Andrew D Clark; Nicole K Banks; Melinda B Henne; Barbara J Stegmann; James H Segars
Journal:  Am J Obstet Gynecol       Date:  2011-12-11       Impact factor: 8.661

9.  Uterine leiomyomata and cesarean birth risk: a prospective cohort with standardized imaging.

Authors:  Kara A Michels; Digna R Velez Edwards; Donna D Baird; David A Savitz; Katherine E Hartmann
Journal:  Ann Epidemiol       Date:  2013-11-12       Impact factor: 3.797

10.  Expanding upon the Human Myometrial Stem Cell Hypothesis and the Role of Race, Hormones, Age, and Parity in a Profibroid Environment.

Authors:  Lauren E Prusinski Fernung; Kimya Jones; Aymara Mas; Daniel Kleven; Jennifer L Waller; Ayman Al-Hendy
Journal:  Am J Pathol       Date:  2018-08-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.